Creation of the Institut Pasteur-UCSF QBI Center of Excellence in Emerging Infectious Diseases Two academic and scientific heavyweights, the Institut Pasteur and UC San Francisco Quantitative Biosciences Institute (UCSF QBI), agree to implement joint actions towards the creation of a center of excellence in emerging infectious diseases with planned operations/locations…..
Longer life due to faulty RNA processing [caption id="" align="aligncenter" width="700"] The roundworm Caenorhabditis elegans is an important model organism in ageing research. The worm in the image is labelled with GFP::RNP-6. Credit: Max Planck Institute for Biology of Ageing[/caption] RNA is an important transmitter of information in our cells…..
Pegcetacoplan treatment shows increased effects over time in geographic atrophy Pegcetacoplan, a targeted C3 therapy designed to regulate excessive activation os the complement cascade, is on track to become the first treatment for geographic atrophy (GA) with a PDFU date of Nov. 26 and EU MAA submission on track by…..
China'BGI Genomics exports its thalassemia detection kits in Azerbaijan Azerbaijan Thalassemia Center will be one of Chinese BGI's pioneer overseas thalassemia projects in a country with a high prevalence rate of this disease. On 6th September 2022, the Azerbaijan Thalassemia Center and BGI Genomics held a virtual signing ceremony to…..
Carroucell has raised €1.5 million Carroucell, a French microcarrier supplier for cell culture in bioreactor, has raised a total of €1.5 million. The funding includes the closing of a Series A financing, led by the Novalis Biotech Acceleration fund and with participation of Crédit Agricole des Savoie (CADS), as well…..
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform AstriVax will draw on technology developed at the KU Leuven Rega Institute (Belgium) to develop novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various pathogens. Closing on…..
Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants
Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variant Researchers at University of Alabama at Birmingham (UAB), Texas Biomedical Research Institute and Aridis Pharmaceuticals discovered a neutralizing monoclonal antibody that potentially acts as a potent universal coronavirus therapy against SARS-CoV-2 and all its variants of concern,…..
New solution for stem cell manufacturing Researchers have developed a unique 3D printed system for harvesting stem cells from bioreactors, offering the potential for high quality, wide-scale production of stem cells in Australia at a lower cost. [caption id="attachment_10614" align="aligncenter" width="700"] Modular 3D printed microfluidic system©Majid Warkiani et al. Bioresources…..
Coriolis Pharma creates a new campus in Martinsried-Munich Coriolis Pharma, a globally operating contract research and development organization (CRDO) and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, ATMP´s and vaccines, is expanding its current headquarters to form a new campus as the next step…..
Early signs support revolutionary potential of EU clinical trials regulation The EU Clinical Trials Regulation should help resolve problems caused by its predecessor directive and help meet needs arising from the pandemic. There will be challenges in doing so, but there is already strong evidence of the benefits awaiting. Evidence…..